CD8A and neoplasm: A comparison of the antitumor protection achieved by adoptively transferred tumor-reactive TCM versus TEM CD8+ T cells revealed that the TCM protective activity is superior to that of TEM, primarily due to the TCM lymphoid homing properties that increase their exposure to tumor-associated antigens presented by DCs42.